Sen. John Boozman Purchases Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Senator John Boozman (R-Arkansas) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on May 14th, the Senator disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on April 16th.

Senator John Boozman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 4/22/2025.
• Purchased $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 4/22/2025.
• Purchased $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Lam Research NASDAQ: LRCX on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of Oracle NYSE: ORCL on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Gilead Sciences NASDAQ: GILD on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/15/2025.
• Sold $1,001 - $15,000 in shares of Bank of America NYSE: BAC on 4/15/2025.
• Purchased $1,001 - $15,000 in shares of iShares iBoxx $ High Yield Corporate Bond ETF NYSEARCA: HYG on 4/9/2025.

UnitedHealth Group Trading Up 6.2%

Shares of UNH traded up $16.89 on Friday, hitting $291.24. 70,463,502 shares of the stock traded hands, compared to its average volume of 5,875,758. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $264.20 billion, a P/E ratio of 18.79, a P/E/G ratio of 1.37 and a beta of 0.56. The stock's 50 day moving average is $470.82 and its two-hundred day moving average is $513.25. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the company posted $6.91 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 2.88%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on UNH shares. KeyCorp dropped their price target on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a research report on Wednesday. Mizuho dropped their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday. Hsbc Global Res lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Deutsche Bank Aktiengesellschaft dropped their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Six research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $486.00.

Insider Transactions at UnitedHealth Group

In other news, CFO John F. Rex acquired 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. NewSquare Capital LLC bought a new position in UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the 4th quarter valued at $28,000. Bayforest Capital Ltd lifted its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the last quarter. Finally, AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $30,000. 87.86% of the stock is currently owned by institutional investors.

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas' U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman's academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.